Loading clinical trials...
Loading clinical trials...
The reason for this study is to see if the study drug ixekizumab is safe and effective in children with juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) (including ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Eli Lilly and Company
NCT06100744 · Juvenile Psoriatic Arthritis
NCT06383195 · Enthesitis Related Arthritis, Enthesitis Related Arthritis, Juvenile
NCT05545839 · Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis, and more
NCT03769168 · Juvenile Psoriatic Arthritis, Enthesitis Related Arthritis
NCT07190053 · Enthesitis-related Arthritis (ERA), Juvenile Psoriatic Arthritis (JPsA)
Instituto CAICI SRL Loc. 15
Rosario, Santa Fe Province
Centro Medico Privado de Reumatologia Loc. 20
San Miguel de Tucumán, Tucumán Province
Cliniques universitaires Saint-Luc
Brussels, Bruxelles-Capitale, Région de
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions